References

1.    1.      Fentiman IS, Fourquet A, Hortobagyi GN: Male breast cancer. Lancet 2006, 367:595-604.

2.      Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U: Male breast cancer: a special therapeutic problem. Anything new? (Review). Int J Oncol 2004, 24:663-670.

3.      Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003; 95(17):1276-1299.

4.      Jemal A, Siegel R, Ward E et al.: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.

5.      Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histologic types and hormone receptors in breast cancer in men: a population- based study in 282 United States men. Cancer Causes Control. 1993;4(2):143-151.

6.      Anderson WF, Althuis MD, Brinton LA, Devesa SS: Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004, 83:77-86.

7.      Agrawal, A., Ayantunde, A. A., Rampaul, R. & Robertson, J. F. Male breast cancer: a review of clinical management. Breast Cancer Res Treat, 2007;103(1), 11-21.

8.      Korde LA, Zujewski JA, Kamin L et al.: Multidisciplinary meeting on Male Brest cancer: summary and research recommend-dations. J Clin Oncol 2010; 28(12): 2114-2122.

9.      Brinon LA, Richesson DA, Gierach GL et al.: Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 2008; 100(20): 1447-1481.

10.  Goodman, M. T., Tung, K. H., Wilkens, L. R. Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000. Cancer Causes Control, 2006;17(2):127-36.

11.  Lanitis, S., Rice, A. J., Vaughan, A., Cathcart, P., Filippakis, G., Al Mufti, R., Hadjiminas, D. J. Diagnosis and management of male breast cancer. World J Surg, 2008;32(11):2471-6.

12.  National Cancer Institute. Surveillance Epidemiology and End Results (SEER): Cancer Statistics. Bethesda (MD): National Cancer Institute 2011. http://seer.cancer.gov/statistics/

13.  Gomez-Raposo C, Zambrana Tevar F, Sereno Moyano M et al.: Male breast cancer. Cancer treat rev 2010; 6(6): 451- 457.

14.  De los Santos, J. F. & Buchholz, T. A. Carcinoma of the male breast. Curr Treat Options Oncol, 2000;1(3):221-7.

15.  Kiluk JV, Lee MC, Park CK et al.: Male breast cancer: management and follow-up recommendations. Breast J 2011; 17(5): 503-509.

16.  Cutuli B, Le-Nir CC, Serin D et al.: Male breast cancer: evolution of treatment and prognostic factors: analysis of 489 cases. Crit rev Oncol Hematol 2010; 73(3): 246-254.

17.  Ribeiro G, Swindell R: Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 1992; 65(2): 252-254.

18.  Ribeiro GG, Swindell R, Harris M et al.: A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 1996; 5: 141-146.

Corresponding Author

Vaibhav Vikas

Government Medical College,

Thiruvananthapuram, Kerala, India